Περίληψη:
The purpose of the European Stroke Organisation-Karolinska Stroke Update
Conference is to provide updates on recent stroke therapy research and
to give an opportunity for the participants to discuss how these results
may be implemented into clinical routine. The meeting started 22 years
ago as Karolinska Stroke Update, but since 2014 it is a joint conference
with European Stroke Organisation. Importantly, it provides a platform
for discussion on the European Stroke Organisation guidelines process
and on recommendations to the European Stroke Organisation guidelines
committee on specific topics. By this, it adds a direct influence from
stroke professionals otherwise not involved in committees and work
groups on the guideline procedure. The discussions at the conference may
also inspire new guidelines when motivated. The topics raised at the
meeting are selected by the scientific programme committee mainly based
on recent important scientific publications. This year's European Stroke
Organisation-Karolinska Stroke Update Meeting was held in Stockholm on
11-13 November 2018. There were 11 scientific sessions discussed in the
meeting including two short sessions. Each session except the short
sessions produced a consensus statement (Full version with background,
issues, conclusions and references are published as web-material and at
and ) and recommendations which were prepared by a writing committee
consisting of session chair(s), scientific secretary and speakers. These
statements were presented to the 250 participants of the meeting. In the
open meeting, general participants commented on the consensus statement
and recommendations and the final document were adjusted based on the
discussion from the general participants Recommendations (grade of
evidence) were graded according to the 1998 Karolinska Stroke Update
meeting with regard to the strength of evidence. Grade A Evidence:
Strong support from randomised controlled trials and statistical reviews
(at least one randomised controlled trial plus one statistical review).
Grade B Evidence: Support from randomised controlled trials and
statistical reviews (one randomised controlled trial or one statistical
review). Grade C Evidence: No reasonable support from randomised
controlled trials, recommendations based on small randomised and/or
non-randomised controlled trials evidence.
Συγγραφείς:
Ahmed, Niaz
Audebert, Heinrich
Turc, Guillaume
Cordonnier,
Charlotte
Christensen, Hanne
Sacco, Simona
Sandset, Else
Charlotte
Ntaios, George
Charidimou, Andreas
Toni, Danilo
and Pristipino, Christian
Koehrmann, Martin
Kuramatsu, Joji B.
and Thomalla, Geotz
Mikulik, Robert
Ford, Gary A. and
Marti-Fabregas, Joan
Fischer, Urs
Thoren, Magnus
Lundstrom,
Erik
Rinkel, Gabriel J. E.
van der Worp, H. Bart and
Matusevicius, Marius
Tsivgoulis, Georgios
Milionis, Haralampos
and Rubiera, Marta
Hart, Robert
Moreira, Tiago
Lantz, Maria
and Sjostrand, Christina
Andersen, Grethe
Schellinger, Peter and
Kostulas, Konstantinos
Sunnerhagen, Katharina Stibrant
Keselman,
Boris
Korompoki, Eleni
Purrucker, Jan
Khatri, Pooja and
Whiteley, William
Berge, Eivind
Mazya, Michael
Dippel,
Diederik W. J.
Mustanoja, Satu
Rasmussen, Mads
Soderqvist,
Asa Kuntze
Escudero-Martinez, Irene
Steiner, Thorsten
